Wendy Chung - 03 Jan 2023 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 17:27:27 UTC
Previous filing
21 Oct 2022
Next filing
19 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +9,482 $0.000000 9,482 03 Jan 2023 Common Stock 9,482 $6.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2023.